November 6, 2019 / 6:09 AM / 12 days ago

BRIEF-Vifor Pharma And Evotec Form Joint Venture For Early Development In Nephrology

Nov 6 (Reuters) - VIFOR PHARMA AG:

* VIFOR PHARMA AND EVOTEC FORM JOINT VENTURE FOR EARLY DEVELOPMENT IN NEPHROLOGY

* VIFOR PHARMA AND EVOTEC SE TODAY ANNOUNCED LAUNCH OF A 50:50 JOINT VENTURE FOCUSED ON DISCOVERY AND DEVELOPMENT OF NOVEL NEPHROLOGY THERAPEUTICS

* WILL BE BENEFITING FROM ACCESS TO AN EXTERNAL RESEARCH AND DEVELOPMENT CAPABILITY FOR DEVELOPMENT OF ITS OWN NEPHROLOGY PIPELINE

* EVOTEC WILL GAIN ACCESS TO A COMMERCIAL PARTNER THROUGH OUTLICENSING ALL NEPHROLOGY ASSETS DEVELOPED THROUGH JOINT VENTURE TO VIFOR PHARMA GROUP

* INITIAL FUNDING OF EUR 25 M FOR PRE-CLINICAL DEVELOPMENT WILL BE COVERED BY VIFOR PHARMA

* CLINICAL AND COMMERCIAL COSTS FOR ANY SUCCESSFUL COMPOUNDS ARE ANTICIPATED TO BE SHARED EQUALLY BY BOTH COMPANIES

* OPT-OUT RIGHTS AT EACH STAGE BASED ON A PREDETERMINED PROFIT SHARE ARRANGEMENT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below